A detailed history of Hixon Zuercher, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hixon Zuercher, LLC holds 65,658 shares of PFE stock, worth $1.7 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
65,658
Holding current value
$1.7 Million
% of portfolio
0.75%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$27.7 - $31.39 $1.82 Million - $2.06 Million
65,658 New
65,658 $1.9 Million
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $16,032 - $20,928
-384 Reduced 1.15%
32,913 $0
Q3 2022

Oct 26, 2022

BUY
$43.76 - $53.42 $82,750 - $101,017
1,891 Added 6.02%
33,297 $1.46 Million
Q2 2022

Jul 12, 2022

SELL
$46.53 - $55.17 $15,866 - $18,812
-341 Reduced 1.07%
31,406 $1.65 Million
Q1 2022

Apr 19, 2022

SELL
$45.75 - $56.69 $30,927 - $38,322
-676 Reduced 2.08%
31,747 $1.64 Million
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $26,031 - $38,587
630 Added 1.98%
32,423 $1.92 Million
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $24,452 - $31,411
623 Added 2.0%
31,793 $1.37 Million
Q2 2021

Oct 13, 2021

BUY
$35.91 - $40.68 $3,088 - $3,498
86 Added 0.28%
31,170 $1.22 Million
Q1 2021

Oct 13, 2021

BUY
$33.49 - $37.77 $67,515 - $76,144
2,016 Added 6.94%
31,084 $1.13 Million
Q4 2020

Oct 13, 2021

SELL
$33.47 - $42.56 $9,036 - $11,491
-270 Reduced 0.92%
29,068 $1.07 Million
Q3 2020

Oct 13, 2021

BUY
$31.75 - $37.25 $15,938 - $18,699
502 Added 1.74%
29,338 $1.08 Million
Q2 2020

Oct 13, 2021

BUY
$30.12 - $36.54 $611,978 - $742,419
20,318 Added 238.53%
28,836 $943,000
Q1 2020

Oct 13, 2021

SELL
$27.03 - $38.62 $7,433 - $10,620
-275 Reduced 3.13%
8,518 $278,000
Q4 2019

Oct 13, 2021

BUY
$32.92 - $37.36 $289,465 - $328,506
8,793 New
8,793 $345,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hixon Zuercher, LLC Portfolio

Follow Hixon Zuercher, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hixon Zuercher, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hixon Zuercher, LLC with notifications on news.